Taxanes propagate apoptosis via two cell populations with distinctive cytological and molecular traits

Cell Growth and Differentiation

Volumn 9, Issue 8, 1998, Pages 687-697

  Moos, Philip J ^a   Fitzpatrick, Frank A ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BCL 2; PROTEIN KINASE; TAXANE DERIVATIVE;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CASPASE 3; CASPASES; CDC2 PROTEIN KINASE; CELL CYCLE; CYCLIN B; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; JURKAT CELLS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MICROTUBULES; MITOGEN-ACTIVATED PROTEIN KINASE 1; NOCODAZOLE; PACLITAXEL; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-RAF; TAXOIDS; ZAP-70 PROTEIN-TYROSINE KINASE;

OXY;

EID: 0031868515     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Schiff, P. B., Fant, J., Auster, L. A., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
2. Rao, S., Orr, G. A., Chaudhary, A. G., Kingston, D. I., and Horowitz, S. B. Characterization of the Taxol binding site on the microtubule: 2-(m-azidobenzoyl) Taxol photolabels a peptide (amino acids 217-231) of β-tubulin. J. Biol. Chem., 270: 20235-20238, 1995.
3. Caplow, M., Shanks, J., and Ruhlen, R. How Taxol modulates microtubule disassembly. J. Biol. Chem., 269: 23399-23402, 1994.
4. Jordan, M. A., Toso, R. J., Thrower, D., and Wilson, L. Mechanism of mitotic block and inhibition of cell proliferation by Taxol at low concentrations. Proc. Natl. Acad. Sci. USA, 90: 9552-9556, 1993.
5. Schiff, P. B., and Horowitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
6. Rowinsky, E. K. The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu. Rev. Med., 48: 353-374, 1997.
7. Von Hoff, D. D. The taxoids: same roots, different drugs. Semin. Oncol. 24: 3-10, 1997.
8. Long, H. J. Paclitaxel (Taxol): a novel anticancer chemotherapeutic drug. Mayo Clin. Proc., 69: 341-345, 1994.
9. Bhalla, K., Ibrado, A. M., Tournika, E., Tang, C., Mahoney, M. E., and Huang, Y. Taxol induces intranucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia (Baltimore), 7: 563-568, 1993.
10. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B., Copp, H., and Wilson, L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res., 56: 816-825, 1996.
11. Woods, C. M., Zhu, J., McQueney, P. A., Bollag, D., and Lazarides, E. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med., 1: 506-526, 1995.
12. 2-M arrest and apoptosis. Nat. Med., 2: 72-79, 1996.
13. Rowinsky, E. K., Donehower, R. C., Jones, R. J., and Tucker, R. W. Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res., 48: 4093-4100, 1988.
14. Gangemi, R. M. R., Tiso, M., Marchetti, C., Severi, A. B., and Fabbi, M. Taxol cytotoxicity on human leukemia cell lines is a function of their susceptibility to programmed cell death. Cancer Chemother. Pharmacol., 36: 385-392, 1995.
15. cdc2 coincident with Taxol-induced apoptosis. Cell Growth Differ., 5: 1041-1050, 1994.
16. cdc2 activation required for apoptosis. Science (Washington DC), 263: 1143-1145, 1994.
17. Manthey, C. L., Brandes, M. E., Perera, P. Y., and Vogel, S. N. Taxol induces steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. J. Immunol., 149: 2549-2465, 1992.
18. Bogdan, C., and Ding, A. Taxol, a microtubule-stabilizing antineoplastic agent, induces expression of tumor necrosis factor I and interleukin-1 in macrophages. J. Leukoc. Biol., 52: 119-121, 1992.
19. Manthey, C. L., Qureshi, N., Stutz, P., and Vogel, S. N. Lipopolysaccharide antagonists block Taxol-induced signaling in murine macrophages. J. Exp. Med., 178: 695-702, 1993.
20. Lanni, J. S., Lowe, S. W., Licitra, E. J., Liu, J. O., and Jacks, T. p53-independent apoptosis induced by paclitaxel through an indirect mechanism. Proc. Natl. Acad. Sci. USA, 94: 9679-9683, 1997.
21. Haldar, S., Jena, N., and Croce, C. M. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA, 92: 4507-4511, 1995.
22. Blagosklonny, M. V., Schulte, T. W., Nguyen, P., Trepel, J., and Neckers, L. M. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 and represents a novel c-Raf-1 signal transduction pathway. Cancer Res., 56: 1851-1854, 1996.
23. Blagosklonny, M. V., Giannakakou, P., El-Deiry, W. S., Kingston, D. G., Higgs, P. I., Neckers, L., and Fojo, T. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death. Cancer Res., 57:130-135, 1997.
24. Haldar, S., Chintapalli, J., and Croce, C. M. Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res., 56: 1253-1255, 1996.
25. Strobel, T., Swanson, L., Korsmeyer, S., and Cannistra, S. A. BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway. Proc. Natl. Acad. Sci. USA, 93: 14094-14099, 1996.
26. L overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells. Cancer Res., 57: 1109-1115, 1997.
27. Burkhart, C. A., Berman, J. W., Swindell, C. S., and Horwitz, S. B. Relationship between the structure of Taxol and other taxanes on induction of tumor necrosis factor a gene expression and cytotoxicity. Cancer Res., 54: 5779-5782, 1994.
28. Oliver, R., Otter, I., Monney, L., Wartmann, M., and Borner, C. Bcl-2 does not require Raf kinase activity for its death-protective function. Biochem. J., 324: 75-83, 1997.
29. WAF1 and p53 requires c-raf-1. Cancer Res., 55: 4623-4626, 1995.
30. Haldar, S., Basu, A., and Croce, C. Bcl2 is the guardian of microtubule integrity. Cancer Res., 57: 229-233, 1997.
31. O'Connor, P. M., Jackman, J., Bae, I., Myers, T. G., Fan, S., Mutoh, M., Scudiero, D. A., Monks, A., Sausville, E. A., Weinstein, J. N., Friend, S., Fornace, A. J., Jr., and Kohn, K. W. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents. Cancer Res., 57: 4285-4300, 1997.
32. Xiang, J., Chao, D. T., and Korsmeyer, S. J. BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA, 93: 14559-14563, 1996.
33. Abraham, I., Wolf, C. L., Sampson, K. E., Laborde, A. L., Shelly, J. A., Aristoff, P. A., and Skulnick, H. I. K252a, KT5720, KT5926, and U98017 support paclitaxel (Taxol)-dependent cells and synergize with paclitaxel. Cancer Res., 54: 5889-5894, 1994.
34. cdc2 kinase activation and apoptosis inhibited by 12-O-tetradecanoylphorbol-13-acetate in human breast MCF-7 carcinoma cells. Cell Growth Differ., 9: 23-29, 1998.
35. Laird, A. D., Taylor, S. J., Oberst, M., and Shalloway, D. Raf-1 is activated during mitosis. J. Biol. Chem., 270: 26742-26745, 1995.
36. Marais, R., Light, Y., Paterson, H. F., and Marshall, C. J. Ras recruits Raf-1 to the plasma membrane for activation by tyrosine phosphorylation. EMBO J., 14: 3136-3145, 1995.
37. Wartmann, M., Hofer, P., Turowski, P., Salteil, A. R., and Hynes, N. E. Negative modulation of membrane localization of the Raf-1 protein kinase by hyperphosphorylation. J. Biol. Chem., 272: 3915-3923, 1997.
38. Stokoe, D., Macdonald, S. G., Cadwallader, K., Symons, M., and Hancock, J. F. Activation of Raf as a result of recruitment to the plasma membrane. Science (Washington DC), 264: 1463-1467, 1994.
39. Jou, P., Kuo, C. J., Reynolds, S. E., Konz, R. F., Raingeaud, J., Davis, R. J., Biemann, H-P., and Blenis, J. Fas activation of the p38 mitogen-activated protein kinase signalling pathway requires ICE/CED-3 family proteases. Mol. Cell. Biol., 17: 24-35, 1997.
40. Cardone, M. H., Salvesen, G. S., Widmann, C., Johnson, G., and Frisch S. M. The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell, 90: 315-323, 1997.
41. Chen, Y-R., Wang, X., Templeton, D., Davis, R. J., and Tan, T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and γ radiation. J. Biol. Chem., 271: 31929-31939, 1996.
42. Rudel, T., and Bokoch, G. M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science (Washington DC), 276: 1571-1574, 1997.
43. Heider, H., Hug, C., and Lucocq, J. M. A 40-kDa myelin basic protein kinase, distinct from erk1 and erk2, is activated in mitotic HeLa cells. Eur. J. Biochem., 219: 513-520, 1994.
44. Wang, T. H., Wang, H. S., Ichijo, H., Giannakakou, P., Fojo, T., and Wimalasena, J. Microtubule-interfering agents activate c-Jun N-terminal kinase/stress-activated protein kinase through both Ras and apoptosis signal-regulating pathways. J. Biol. Chem., 273: 4928-4936, 1998.
45. 2-terminal kinase activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. Cancer Res., 58: 241-247, 1998.
46. Fry, A. M., Schultz, S. J., Bartek, J., and Nigg, E. A. Substrate specificity and cell cycle regulation of the Nek2 protein kinase, a potential human homolog of the mitotic regulator NIMA of Aspergillus nidulans. J. Biol. Chem., 270: 12899-12905, 1995.
47. Kameshita, I., and Fujisawa, H. A sensitive method for the detection of calmodulin-dependent protein kinase II activity in sodium dodecyl sulfate-polyacrylamide gel. Anal. Biochem., 183: 139-143, 1989.
48. Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997.
49. Idziorek, T., Estaquier, J., De Bels, F., and Ameisen, J-C. YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J. Immunol. Methods, 185: 249-258, 1995.